CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

Clindamycin Phosphate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 18 USDMF, 13 CEP/COS, 6 JDMF, 1 EU WC, 2 KDMF, 14 NDC API, 19 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

240 FDF Dossiers, 134 FDA Orange Book, 79 Europe, 16 Canada, 1 South Africa, 10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML), INJECTABLE;INJECTION - EQ 150MG BASE/ML, SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - EQ 1% BASE, GEL;TOPICAL - EQ 1% BASE, GEL;TOPICAL - 5%;1.2%, GEL;TOPICAL - 5%;EQ 1% BASE, SUPPOSITORY;VAGINAL - 100MG, GEL;TOPICAL - EQ 1% BASE, CREAM;VAGINAL - EQ 2% BASE, AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 3 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 1 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 6 Kirsch Pharma, 8 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 13 BASF, 1 BioSpectra, 2 CD Formulation, 1 Clariant, 6 Corel Pharma Chem, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 1 Kerry, 5 Lubrizol Life Science Health, 4 Microlex e.U, 1 Nanjing Bold Chemical, 2 Pluviaendo, 16 Roquette, 10 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

38 Topical, 27 Thickeners and Stabilizers, 27 Parenteral, 25 Solubilizers, 16 Emulsifying Agents, 16 Film Formers & Plasticizers, 13 Fillers, Diluents & Binders, 9 Surfactant & Foaming Agents, 7 Direct Compression, 7 Controlled & Modified Release, 7 Rheology Modifiers, 7 Coating Systems & Additives, 6 Lubricants & Glidants, 5 Taste Masking, 4 Granulation, 3 Chewable & Orodispersible Aids, 3 Co-Processed Excipients, 3 API Stability Enhancers, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 57 News #PharmaBuzz

GLOBAL SALES INFORMATION

29 US Medicaid Prescriptions, 8 Regulatory FDF Prices

MARKET PLACE

35 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
31/10/2025	Chongqing Carelife Pharmaceutical	China	Chungking Carelife Pharmaceutical Co., Ltd.	229MF10180	Clindamycin phosphate	2017-09-25	2024-01-30	3 Hua Nanyi Road, Chongqing (Changshou) Chemical Industrial Park, Chongqing 401254
31/10/2025	Suzhou no. 4 Pharmaceutical Factory	China	Suzhou Fourth Pharmaceutical Factory Co., Ltd.	218MF10538	Japanese Pharmacopoeia Clindamycin Phosphate	2006-06-01	2007-09-10	No. 171, Baiyangwan Street, Suzhou City

Clindamycin Phosphate

Clindamycin Phosphate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers

18 USDMF

13 CEP/COS

6 JDMF

1 EU WC

2 KDMF

14 NDC API

19 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

240 FDF Dossiers

134 FDA Orange Book

79 Europe

16 Canada

1 South Africa

10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML)

INJECTABLE;INJECTION - EQ 150MG BASE/ML

SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION;TOPICAL - EQ 1% BASE

GEL;TOPICAL - EQ 1% BASE

GEL;TOPICAL - 5%;1.2%

GEL;TOPICAL - 5%;EQ 1% BASE

SUPPOSITORY;VAGINAL - 100MG

GEL;TOPICAL - EQ 1% BASE

CREAM;VAGINAL - EQ 2% BASE

AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

3 SPI Pharma

5 DKSH

1 Pharm-RX Chemical

1 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Pfanstiehl

6 Kirsch Pharma

8 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

13 BASF

1 BioSpectra

2 CD Formulation

1 Clariant

6 Corel Pharma Chem

1 Esteem Industries

2 Finar

7 Gangwal Chemicals

1 Kerry

5 Lubrizol Life Science Health

4 Microlex e.U

1 Nanjing Bold Chemical

2 Pluviaendo

16 Roquette

10 Seppic

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

38 Topical

27 Thickeners and Stabilizers

27 Parenteral

25 Solubilizers

16 Emulsifying Agents

16 Film Formers & Plasticizers

SOLUTION;TOPICAL - EQ 1% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, FOAM;TOPICAL - 1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons